ALPS Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-28,212
| Closed | -$66K | – | 1100 |
|
|
2022
Q3 | $66K | Sell |
28,212
-2,444
| -8% | -$5.72K | ﹤0.01% | 1036 |
|
|
2022
Q2 | $93K | Sell |
30,656
-22,468
| -42% | -$68.2K | ﹤0.01% | 1026 |
|
|
2022
Q1 | $361K | Sell |
53,124
-6,174
| -10% | -$42K | ﹤0.01% | 611 |
|
|
2021
Q4 | $495K | Buy |
+59,298
| New | +$495K | 0.01% | 502 |
|
|
2018
Q4 | – | Sell |
-57,738
| Closed | -$375K | – | 965 |
|
|
2018
Q3 | $375K | Buy |
57,738
+10,600
| +22% | +$68.8K | ﹤0.01% | 882 |
|
|
2018
Q2 | $361K | Buy |
47,138
+3,999
| +9% | +$30.6K | ﹤0.01% | 821 |
|
|
2018
Q1 | $964K | Buy |
43,139
+7,497
| +21% | +$168K | 0.01% | 319 |
|
|
2017
Q4 | $454K | Buy |
35,642
+3,966
| +13% | +$50.5K | ﹤0.01% | 638 |
|
|
2017
Q3 | $494K | Buy |
31,676
+2,644
| +9% | +$41.2K | ﹤0.01% | 546 |
|
|
2017
Q2 | $407K | Buy |
+29,032
| New | +$407K | ﹤0.01% | 676 |
|